Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 15, Pages 2125-2132
Publisher
Informa Healthcare
Online
2013-09-05
DOI
10.1517/14656566.2013.833605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
- (2012) W. D. Chey et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints
- (2012) E. M. M. Quigley et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
- (2012) Satish Rao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP4)
- (2012) Yohei Norimatsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
- (2012) Rebecca M. Lovell et al. Clinical Gastroenterology and Hepatology
- Chronic constipation: new diagnostic and treatment approaches
- (2012) Brian E. Lacy et al. Therapeutic Advances in Gastroenterology
- Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study
- (2011) M. Simrén et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
- (2011) William D Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Two Randomized Trials of Linaclotide for Chronic Constipation
- (2011) Anthony J. Lembo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies
- (2010) M. Camilleri et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
- (2010) Robert W. Busby et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
- (2010) Jeffrey M. Johnston et al. GASTROENTEROLOGY
- Efficacy of Linaclotide for Patients With Chronic Constipation
- (2010) Anthony J. Lembo et al. GASTROENTEROLOGY
- Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract
- (2010) Alexander P. Bryant et al. LIFE SCIENCES
- Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation
- (2008) Jeffrey M Johnston et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started